<VariationArchive VariationID="279703" VariationName="NM_152743.4(BRAT1):c.294dup (p.Leu99fs)" VariationType="Duplication" Accession="VCV000279703" Version="40" RecordType="classified" NumberOfSubmissions="16" NumberOfSubmitters="16" DateLastUpdated="2024-07-23" DateCreated="2016-12-06" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="264325" VariationID="279703">
      <GeneList>
        <Gene Symbol="BRAT1" FullName="BRCA1 associated ATM activator 1" GeneID="221927" HGNC_ID="HGNC:21701" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7p22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="2537810" stop="2555524" display_start="2537810" display_stop="2555524" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="2577443" stop="2595391" display_start="2577443" display_stop="2595391" Strand="-" />
          </Location>
          <OMIM>614506</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_152743.4(BRAT1):c.294dup (p.Leu99fs)</Name>
      <CanonicalSPDI>NC_000007.14:2545044:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>7p22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="2545044" stop="2545045" display_start="2545044" display_stop="2545045" variantLength="1" positionVCF="2545044" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="2584678" stop="2584679" display_start="2584678" display_stop="2584679" variantLength="1" positionVCF="2584678" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <ProteinChange>L99fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.2584679dup" Assembly="GRCh37">
            <Expression>NC_000007.13:g.2584679dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.2545045dup" Assembly="GRCh38">
            <Expression>NC_000007.14:g.2545045dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032167.1" sequenceAccession="NG_032167" sequenceVersion="1" change="g.15714dup">
            <Expression>NG_032167.1:g.15714dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001350626.2" sequenceAccession="NM_001350626" sequenceVersion="2" change="c.294dup">
            <Expression>NM_001350626.2:c.294dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001337555.1" sequenceAccession="NP_001337555" sequenceVersion="1" change="p.Leu99fs">
            <Expression>NP_001337555.1:p.Leu99fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152743.4" sequenceAccession="NM_152743" sequenceVersion="4" change="c.294dup" MANESelect="true">
            <Expression>NM_152743.4:c.294dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_689956.2" sequenceAccession="NP_689956" sequenceVersion="2" change="p.Leu99fs">
            <Expression>NP_689956.2:p.Leu99fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_146879.2" sequenceAccession="NR_146879" sequenceVersion="2" change="n.353dup">
            <Expression>NR_146879.2:n.353dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001350627.2" sequenceAccession="NM_001350627" sequenceVersion="2" change="c.-95-1083dup">
            <Expression>NM_001350627.2:c.-95-1083dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152743.3" sequenceAccession="NM_152743" sequenceVersion="3" change="c.294dupA">
            <Expression>NM_152743.3:c.294dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA4128245" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="614506.0006" DB="OMIM" />
        <XRef Type="rs" ID="776913277" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00016" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
        <AlleleFrequency Value="0.00019" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00022" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00024" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00079" Source="Exome Aggregation Consortium (ExAC)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_152743.4(BRAT1):c.294dup (p.Leu99fs) AND not provided" Accession="RCV000372314" Version="21">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-05-31" SubmissionCount="6">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_152743.4(BRAT1):c.294dup (p.Leu99fs) AND Neonatal-onset encephalopathy with rigidity and seizures" Accession="RCV000500824" Version="24">
        <ClassifiedConditionList TraitSetID="7926">
          <ClassifiedCondition DB="MedGen" ID="C3281029">Neonatal-onset encephalopathy with rigidity and seizures</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-28" SubmissionCount="7">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_152743.4(BRAT1):c.294dup (p.Leu99fs) AND Neurodevelopmental disorder with cerebellar atrophy and with or without seizures" Accession="RCV000677129" Version="5">
        <ClassifiedConditionList TraitSetID="44005">
          <ClassifiedCondition DB="MedGen" ID="C4748032">Neurodevelopmental disorder with cerebellar atrophy and with or without seizures</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-04-13" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_152743.4(BRAT1):c.294dup (p.Leu99fs) AND Inborn genetic diseases" Accession="RCV002519031" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-11-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-28" NumberOfSubmissions="16" NumberOfSubmitters="16" DateCreated="2016-12-06" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22279524</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25500575</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26483087</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26494257</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28635423</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31345272</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32964447</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=BRAT1</URL>
        </Citation>
        <DescriptionHistory Dated="2020-12-10">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7926" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16850" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lethal neonatal spasticity-epileptic encephalopathy syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neonatal-onset encephalopathy with rigidity and seizures</ElementValue>
                <XRef ID="MONDO:0013784" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rigidity and multifocal seizure syndrome, lethal neonatal</ElementValue>
                <XRef ID="RIGIDITY+AND+MULTIFOCAL+SEIZURE+SYNDROME%2C+LETHAL+NEONATAL/9257" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">RMFSL</ElementValue>
                <XRef Type="MIM" ID="614498" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17718" />
                <XRef ID="17718" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="435845" DB="Orphanet" />
              <XRef ID="C3281029" DB="MedGen" />
              <XRef ID="MONDO:0013784" DB="MONDO" />
              <XRef Type="MIM" ID="614498" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="44005" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="40393" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neurodevelopmental disorder with cerebellar atrophy and with or without seizures</ElementValue>
                <XRef ID="MONDO:0020841" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NEDCAS</ElementValue>
                <XRef Type="MIM" ID="618056" DB="OMIM" />
              </Symbol>
              <XRef ID="C4748032" DB="MedGen" />
              <XRef ID="MONDO:0020841" DB="MONDO" />
              <XRef Type="MIM" ID="618056" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1150100" SubmissionDate="2017-07-05" DateLastUpdated="2017-08-28" DateCreated="2017-08-28">
        <ClinVarSubmissionID localKey="NM_152743.3(BRAT1):c.294dup|Rigidity and multifocal seizure syndrome, lethal neonatal" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000593656" DateUpdated="2017-08-28" DateCreated="2017-08-28" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-01-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BRAT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_152743.3:c.294dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Rigidity and multifocal seizure syndrome, lethal neonatal</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2843028</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1190797" SubmissionDate="2017-10-05" DateLastUpdated="2016-12-06" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="88799429" />
        <ClinVarAccession Accession="SCV000610742" DateUpdated="2016-12-06" DateCreated="2016-12-06" Type="SCV" Version="1" SubmitterName="Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics" OrgID="505698" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-06-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>Homo sapiens</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>Illumina</NamePlatform>
              <TypePlatform>Sequencing</TypePlatform>
              <ResultType>variant call</ResultType>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0.000462</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Insertion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" Strand="+" alternateAllele="T" referenceAllele="-" start="2584678" stop="2584679" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1566052" SubmissionDate="2018-08-02" DateLastUpdated="2018-08-06" DateCreated="2018-08-06">
        <ClinVarSubmissionID localKey="614506.0006_NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND SEIZURES" title="BRAT1, 1-BP DUP, 294A_NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND SEIZURES" />
        <ClinVarAccession Accession="SCV000803199" DateUpdated="2018-08-06" DateCreated="2018-08-06" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-02">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 3.5-year-old girl with neurodevelopmental disorder with cerebellar atrophy and seizures (NEDCAS; 618056), Hanes et al. (2015) identified compound heterozygous mutations in the BRAT1 gene: a 1-bp duplication (c.294dupA), predicted to result in a frameshift and premature termination, and a c.1825C-T transition, predicted to result in an arg609-to-trp (R609W; 614506.0007) substitution. The mutations, which were found by next-generation sequencing of a neurologic gene panel, segregated with the disorder in the family. The variants had not previously been published as mutations or reported as benign polymorphisms. Functional studies of the variants and studies of patient cells were not performed, but the frameshift mutation was predicted to result in a loss of protein function, and the R609W mutation was predicted to affect the secondary structure of the protein and adversely affect function. Hanes et al. (2015) noted that this patient had later onset of the disorder and was still alive at the time of the report, unlike patients with lethal neonatal rigidity and multifocal seizure syndrome (RMFSL; 614498).</Attribute>
              <Citation>
                <ID Source="PubMed">26483087</ID>
              </Citation>
              <XRef DB="OMIM" ID="618056" Type="MIM" />
              <XRef DB="OMIM" ID="614498" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 6-year-old girl with NEDCAS, Mundy et al. (2016) identified compound heterozygosity for 2 mutations in the BRAT1 gene: c.294dupA, predicted to result in a frameshift and premature termination (Leu99fs), and a c.1925C-A transversion, resulting in an ala642-to-glu (A642E; 614506.0011) substitution. The mutations, which were found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. The c.294dupA mutation was found at a low frequency in the ExAC database (0.13%), whereas the A642E mutation was not found in human genomics databases. Functional studies of the variants and studies of patient cells were not performed.</Attribute>
              <Citation>
                <ID Source="PubMed">26494257</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BRAT1" />
          </GeneList>
          <Name>BRAT1, 1-BP DUP, 294A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 294A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614506.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND SEIZURES</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1675538" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-16" DateCreated="2018-12-16">
        <ClinVarSubmissionID localKey="66879_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000858548" DateUpdated="2018-12-16" DateCreated="2018-12-16" Type="SCV" Version="1" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BRAT1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" alternateAllele="TT" referenceAllele="T" start="2584679" stop="2584679" variantLength="1" />
            <GeneLocation>NM_152743.3:Ex4</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI162273" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=BRAT1</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1893929" SubmissionDate="2019-02-15" DateLastUpdated="2019-08-26" DateCreated="2019-08-26">
        <ClinVarSubmissionID localKey="PED5153.12|OMIM:614498" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000966182" DateUpdated="2019-08-26" DateCreated="2019-08-26" Type="SCV" Version="1" SubmitterName="Equipe Genetique des Anomalies du Developpement, Université de Bourgogne" OrgID="506039" OrganizationCategory="laboratory" OrgAbbreviation="GADteam" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-07-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BRAT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_152743.3:c.294dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614498" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5151712</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1954687" SubmissionDate="2019-09-20" DateLastUpdated="2019-10-19" DateCreated="2019-10-19">
        <ClinVarSubmissionID localKey="c.294dupA" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000996133" DateUpdated="2019-10-19" DateCreated="2019-10-19" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-04-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This frameshifting variant is predicted to result in a premature stop codon and is therefore considered a loss-of-function mutation. This variant has been previously reported as a compound heterozygous change in individuals with neurodevelopmental phenotypes of variable severity (PMID: 26494257, 26483087). This variant is present as a heterozygous change in the gnomAD population database at a frequency of 0.023%. Based on the available evidence, the c.294dupA (p.Leu99ThrfsTer92) variant is classified as a pathogenic change.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">135</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BRAT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_152743.3:c.294dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6324741</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2862718" SubmissionDate="2020-11-26" DateLastUpdated="2020-12-11" DateCreated="2020-12-11">
        <ClinVarSubmissionID localKey="NM_152743.4:c.294dup|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001449852" DateUpdated="2020-12-11" DateCreated="2020-12-11" Type="SCV" Version="1" SubmitterName="Clinical Genetics and Genomics, Karolinska University Hospital" OrgID="505315" OrganizationCategory="laboratory" OrgAbbreviation="KLINGEN-KUS" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-12-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="6" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BRAT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_152743.4:c.294dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8639822</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5409129" SubmissionDate="2022-12-20" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="36-20220820" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002764904" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München" OrgID="500240" OrganizationCategory="clinic" OrgAbbreviation="IHG-MRI-TUM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Classification criteria August 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/inodbbrd/classification_criteria.pdf</URL>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Disease">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0011968" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0200134" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Disease">
                <XRef DB="HP" ID="HP:0002643" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BRAT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" alternateAllele="GT" referenceAllele="G" start="2584678" stop="2584678" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614498" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MRIHUMGEN_STATUS_20220809</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7159615" SubmissionDate="2023-02-19" DateLastUpdated="2023-03-11" DateCreated="2023-03-11">
        <ClinVarSubmissionID localKey="5087|OMIM:618056" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003834870" DateUpdated="2023-03-11" DateCreated="2023-03-11" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_152743.4:c.294dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="618056" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12876118</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="642354" SubmissionDate="2023-06-07" DateLastUpdated="2023-06-10" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="GDXSV:274004" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000329114" DateUpdated="2023-06-10" DateCreated="2016-12-06" Type="SCV" Version="7" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 27282546, 26494257, 27480663, 27282648, 31440721, 31980526, 28635423, 32964447, 26483087, 33726816, 35620305)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BRAT1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:7032</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_152743.3:c.294dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_149_20221207054205</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_195_20230607054203</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3963413" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="22bc05c9ba63ef183ea76a8439bcba13caf0cc5dc8834dbec86518aa076d32f7|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002022758" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_152743.4:c.294dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1250442" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="1446041|MedGen:C3281029" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000652262" DateUpdated="2024-02-20" DateCreated="2017-12-26" Type="SCV" Version="9" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22279524</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25500575</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26483087</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26494257</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu99Thrfs*92) in the BRAT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BRAT1 are known to be pathogenic (PMID: 22279524, 25500575). This variant is present in population databases (rs776913277, gnomAD 0.08%). This premature translational stop signal has been observed in individual(s) with neonatal onset of hypertonia and seizures and progressive global developmental delay, visual impairment, microcephaly, hypertonia, hyperreflexia, and seizures (PMID: 26483087, 26494257). ClinVar contains an entry for this variant (Variation ID: 279703). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BRAT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.2584678_2584679insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3281029" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9056810" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="111917261|Orphanet:ORPHA435845" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004847452" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26494257</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32964447</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31345272</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26483087</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28635423</ID>
          </Citation>
          <Comment>The p.Leu99ThrfsX92 variant in BRAT1 has been reported in the compound heterozygous state (confirmed in trans) in at least 5 individuals with clinical features of variable severity consistent with BRAT1-associated neurodevelopmental disorders and segregated with the phenotype in 2 affected relatives from 1 family (Hanes 2015 PMID: 26483087, Mundy 2016 PMID: 26494257, Oatts 2017 PMID: 28635423, Taylor 2019 PMID: 31345272, Stodberg 2020 PMID: 32964447). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID 279703) and has been identified in 0.09% (22/24284) of Ashkenazi Jewish chromosomes by gnomAD (http://gnomad.broadinstitute.org, v4.0.0), consistent with a recessive carrier frequency. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 99 and leads to a premature termination codon 92 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Biallelic loss of function of the BRAT1 gene is an established disease mechanism in autosomal recessive BRAT1-related neurodevelopmental disorder. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive BRAT1-related neurodevelopmental disorders. ACMG/AMP Criteria applied: PVS1, PP1_Moderate, PM3.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BRAT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_001350626.2:exon 4</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.14:g.2545044_2545045insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA435845" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6299982" SubmissionDate="2024-04-19" DateLastUpdated="2024-05-01" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="a635543|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003612338" DateUpdated="2024-05-01" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-11-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26483087</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26494257</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28635423</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31345272</ID>
          </Citation>
          <Comment>The c.294dupA (p.L99Tfs*92) alteration, located in exon 4 (coding exon 3) of the BRAT1 gene, consists of a duplication of A at position 294, causing a translational frameshift with a predicted alternate stop codon after 92 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from the Genome Aggregation Database (gnomAD) database, the BRAT1 c.294dupA alteration was observed in 0.02% (42/173320) of total alleles studied, with a frequency of 0.07% (3/4034) in the Ashkenazi Jewish subpopulation. This alteration has been described with a second alteration in trans in multiple unrelated patients who present with developmental delay, microcephaly, abnormal muscle tone, and various other anomalies (Hanes, 2015; Mundy, 2015; Oatts, 2017, Taylor, 2019)._x000D_ _x000D_ Manual edits for references:_x000D_ _x000D_ Mundy SA, et al. (2015) Am. J. Med. Genet. A 170(3):699-702._x000D_ Oatts JT, et al. (2017) Ophthalmic Genet. 38(6):1-3. Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BRAT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_152743.3:c.294dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>AVA4 Submission_Through01042023</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7742787" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="153818|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004158796" DateUpdated="2024-07-15" DateCreated="2023-11-20" Type="SCV" Version="7" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>BRAT1: PVS1, PM2, PM3</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BRAT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" alternateAllele="GT" referenceAllele="G" start="2584678" stop="2584678" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5003083" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2022-08-08">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_152743_3_BRAT1_c_294dupA" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002557277" DateUpdated="2024-07-23" DateCreated="2022-08-08" Type="SCV" Version="2" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32964447</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with neurodevelopmental disorder with cerebellar atrophy and with or without seizures (MIM#618056) and lethal neonatal rigidity and multifocal seizure syndrome (MIM#614498). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) &lt;0.01 for a recessive condition (42 heterozygotes, 0 homozygotes). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. These variants have been reported many times as pathogenic, and observed in individuals with neurodevelopmental disorder with cerebellar atrophy, with or without seizures, or lethal neonatal rigidity and multifocal seizure syndrome (DECIPHER). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported many times as pathogenic and likely pathogenic, and observed in individuals with brain malformations (ClinVar, PMID: 32964447). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BRAT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_13892</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_152743.3:c.294dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0013784" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_32</SubmissionName>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1893929" TraitType="Disease" MappingType="XRef" MappingValue="614498" MappingRef="OMIM">
        <MedGen CUI="C3281029" Name="Neonatal-onset encephalopathy with rigidity and seizures" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5409129" TraitType="Disease" MappingType="XRef" MappingValue="HP:0002643" MappingRef="HP">
        <MedGen CUI="C4281993" Name="Neonatal respiratory distress" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1150100" TraitType="Disease" MappingType="Name" MappingValue="Rigidity and multifocal seizure syndrome, lethal neonatal" MappingRef="Preferred">
        <MedGen CUI="C3281029" Name="Neonatal-onset encephalopathy with rigidity and seizures" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6299982" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="642354" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5409129" TraitType="Disease" MappingType="XRef" MappingValue="HP:0200134" MappingRef="HP">
        <MedGen CUI="C0543888" Name="Epileptic encephalopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1675538" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3963413" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5409129" TraitType="Disease" MappingType="XRef" MappingValue="HP:0011968" MappingRef="HP">
        <MedGen CUI="C0232466" Name="Feeding difficulties" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5409129" TraitType="Disease" MappingType="XRef" MappingValue="614498" MappingRef="OMIM">
        <MedGen CUI="C3281029" Name="Neonatal-onset encephalopathy with rigidity and seizures" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2862718" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1250442" TraitType="Disease" MappingType="XRef" MappingValue="C3281029" MappingRef="MedGen">
        <MedGen CUI="C3281029" Name="Neonatal-onset encephalopathy with rigidity and seizures" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5003083" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0013784" MappingRef="MONDO">
        <MedGen CUI="C3281029" Name="Neonatal-onset encephalopathy with rigidity and seizures" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1190797" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7159615" TraitType="Disease" MappingType="XRef" MappingValue="618056" MappingRef="OMIM">
        <MedGen CUI="C4748032" Name="Neurodevelopmental disorder with cerebellar atrophy and with or without seizures" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1954687" TraitType="Disease" MappingType="Name" MappingValue="RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL" MappingRef="Preferred">
        <MedGen CUI="C3281029" Name="Neonatal-onset encephalopathy with rigidity and seizures" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9056810" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA435845" MappingRef="Orphanet">
        <MedGen CUI="C3281029" Name="Neonatal-onset encephalopathy with rigidity and seizures" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7742787" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001526222</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

